Nearly half of women in Africa will be obese or overweight by 2030
|
Stigma, lack of treatment and disproportionate rise of the
disease in women draws comparisons with HIV epidemic. |
Gilead's lenacapavir applications for HIV gain EMA validation
Gilead's lenacapavir gained approval in several nations for treating the adult population with multi-drug resistant HIV in conjunction with other ... View article...